N
NRX Pharmaceuticals D
D
NRXP
3.25000
USD
0.00
(0.00%)
مغلق
حجم التداول
1,662
الربح لكل سهم
-0
العائد الربحي
-
P/E
-2
حجم السوق
56,189,874
الأخبار المقالات
العنوان: NRX Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.